On July 31, 2026, the Health Resources and Services Administration (HRSA) announced a revised 340B…
Eve LingaitisAugust 31, 2026
In May 2026, several major health systems—including Mount Sinai Health System, University of Michigan Health,…
Eve LingaitisJune 30, 2026
Today, April 20, 2026, is the final day for stakeholders to submit comments on HRSA's…
Eve LingaitisApril 20, 2026
Nearly 100 bipartisan House members (led by Reps. Matsui, Johnson, Dingell, and Mann) sent a…
Eve LingaitisApril 8, 2026
If you've been watching the 340B landscape over the past few years and telling yourself…
Eve LingaitisMarch 25, 2026
Landmark Ruling Reinforces Safeguards for Safety-Net Providers Amid Pharmaceutical Industry Challenges In a significant development…
Alex CullorMay 27, 2025
How Clarifying 340B Duplicate Discount Policies Can Strengthen Patient Access and Provider Sustainability The 340B…
Alex CullorApril 9, 2025
The 340B Drug Pricing Program is facing unprecedented pressure. A growing number of pharmaceutical manufacturers…
Alex CullorMarch 26, 2025
In a bold step toward making healthcare more affordable, the Centers for Medicare & Medicaid…
Alex CullorMarch 26, 2025
